non platinum-based chemotherapy for COVID-19: living meta-analysis of clinical studies

display ongoing

results: demonstrated suggested inconclusive safety concern ongoing study

	breast cancer - HER2-positive	breast cancer - HR positive

	es-BC - HER2 positive - (neo)adjuvant (NA)	la/mBC - HR positive
non platinum-based chemotherapy
microtubul inhibitor
eribulin		NCT03051659
taxanes
paclitaxel
paclitaxel followed by doxorubicin plus cyclophosphamide	IMpassion-050 IMpassion-050 IMpassion-050

Study type: